IRIS UniCatt

Bottoni, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.832
EU - Europa 1.327
AS - Asia 1.269
SA - Sud America 239
AF - Africa 30
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.703
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.777
SG - Singapore 495
CN - Cina 443
DE - Germania 407
SE - Svezia 203
UA - Ucraina 203
BR - Brasile 195
IT - Italia 99
FR - Francia 75
IE - Irlanda 71
GB - Regno Unito 69
FI - Finlandia 58
VN - Vietnam 54
IN - India 53
TR - Turchia 51
ID - Indonesia 46
RU - Federazione Russa 46
CA - Canada 36
BD - Bangladesh 21
JP - Giappone 19
AR - Argentina 17
HK - Hong Kong 17
BE - Belgio 16
KR - Corea 16
ES - Italia 15
NL - Olanda 12
IQ - Iraq 11
MX - Messico 9
CH - Svizzera 8
PK - Pakistan 8
ZA - Sudafrica 8
PL - Polonia 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
MA - Marocco 6
SA - Arabia Saudita 6
AT - Austria 5
PY - Paraguay 5
RO - Romania 5
DZ - Algeria 4
EC - Ecuador 4
IL - Israele 4
IR - Iran 4
MY - Malesia 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CL - Cile 3
CO - Colombia 3
DK - Danimarca 3
EG - Egitto 3
KE - Kenya 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
LT - Lituania 2
LU - Lussemburgo 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
ME - Montenegro 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 4.703
Salva come PNG Salva come JPEG
Città #
Chandler 294
Singapore 204
Ashburn 147
Jacksonville 103
San Mateo 76
Beijing 75
Nanjing 72
New York 71
Dublin 67
Wilmington 48
The Dalles 47
Ann Arbor 46
Hefei 43
Redmond 43
Izmir 42
Jakarta 40
Los Angeles 40
Woodbridge 40
Dearborn 37
Houston 37
Boston 31
Chicago 30
Lawrence 30
Bremen 24
Moscow 23
Cattolica 21
Fairfield 20
Seattle 20
São Paulo 19
Detroit 18
Hanoi 18
Boardman 16
Frankfurt am Main 16
Ho Chi Minh City 16
Hong Kong 16
Kent 16
Kunming 16
Montreal 15
Mountain View 15
Nanchang 15
Nürnberg 14
Zhengzhou 14
Helsinki 13
Redwood City 13
Shanghai 13
Brussels 12
Munich 12
Hangzhou 11
Hebei 11
London 11
Rome 11
Seoul 11
Philadelphia 10
Shenyang 10
Tokyo 10
Brooklyn 9
Princeton 9
Pune 9
Toronto 9
Guangzhou 8
Milan 8
University Park 8
Belo Horizonte 7
Buffalo 7
Cambridge 7
Düsseldorf 7
Lancaster 7
Chengdu 6
Dallas 6
Edinburgh 6
Madrid 6
Santa Clara 6
Tianjin 6
Turku 6
Atlanta 5
Dhaka 5
Indiana 5
Jiaxing 5
Johannesburg 5
Orem 5
Simi Valley 5
Zurich 5
Biên Hòa 4
Brasília 4
Changsha 4
Curitiba 4
Lansing 4
Lanzhou 4
Littleton 4
Marseille 4
Norwalk 4
Ottawa 4
Poplar 4
Portsmouth 4
Rio de Janeiro 4
Stockholm 4
Uberlândia 4
Valparaíso de Goiás 4
Warsaw 4
Baghdad 3
Totale 2.391
Salva come PNG Salva come JPEG
Nome #
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects 185
CA 19-9: Biochemical and Clinical Aspects 177
MITOCHONDRIAL DAMAGE AND METABOLIC COMPENSATORY MECHANISMS INDUCED BY HYPEROXIA IN U-937 CELL LINE. 170
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds Through Structure-Based Drug Design and Docking Studies 163
Neuron Specific Enolase as a biomarker: biochemical and clinical aspects 158
A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line 156
Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer 148
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. 147
A Critical Approach to Clinical Biochemistry of Chromogranin A 142
An update on pharmacological approaches to neurodegenerative diseases. 140
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects 140
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. 139
Advances in Mitochondrial Medicine 137
CA 19-9: Biochemical and Clinical Aspects 133
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole C2 and/or C4 Substitutions on Biological Activity 131
Bezafibrate Induces a Mitochondrial Derangement in Human Cell Lines. Intriguing Effects for a Peroxisome Proliferator. 131
The epithelial–mesenchymal transition in cancer: a potential critical topic for translational proteomic research 130
Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy 125
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. 123
Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function,phenotype and differentiation with potential clinical applications. 123
Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer. 117
The proteomics of cancer stem cells. Potential clinical applications for innovative research in oncology 117
Cancer stem cells: the development of new cancer therapeutics 115
A critical approach to clinical biochemistry of Chromogranin A 112
The role of CA 125 as tumor marker: biochemical and clinical aspects 110
CA 19-9: Biochemical and Clinical Aspects 110
Cancer Stem Cells: An Innovative Therapeutic Approach 107
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications 103
Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. 103
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. 103
Cancer Stem Cells: Proteomic Approaches for New Potential Diagnostic and Prognostic Biomarkers 97
Glycolytic enzyme inhibitors in cancer treatment. 93
Advances in Heat Shock Proteomics: Towards a Better Understanding of the Physiology and Pathophysiology of Molecular Chaperones. 93
Mitochondrial respiration and differentiation 88
Cellular respiration and dedifferentiation 82
Aroyl-Pyrrolyl Hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetilase inhibition 82
Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates. 78
Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition. 66
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? 57
Totale 4.731
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.893
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021205 0 0 0 0 0 36 36 3 50 7 64 9
2021/2022343 29 39 4 39 21 16 8 56 8 17 37 69
2022/2023792 100 107 60 124 78 91 13 77 81 20 33 8
2023/2024319 19 95 4 7 12 62 13 13 4 13 45 32
2024/2025729 22 17 51 26 70 25 19 50 99 86 128 136
2025/2026977 270 56 108 175 269 99 0 0 0 0 0 0
Totale 4.731